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The Pedagogical Significance of the Bush Stem Cell
Policy: A Window into Bioethical Regulation in the United
States
0. Carter Snead, J.D.*
The enormous significance of the Bush stem cell funding policy has
been evident since its inception. The announcement of the policy on
August 9, 2001 marked the first time a U.S. president had ever taken up a
matter of bioethical import as the sole subject of a major national policy
address. Indeed, the August 9th speech was the President's first nationally
televised policy address of any kind.1 Since then, the policy has been a
constant focus of attention and discussion by political commentators, the
print and broadcast media, advocacy organizations, scientists, elected
officials, and candidates for all levels of office (including especially the
2004 Democratic nominee for President, Senator John Kerry, who made
his opposition to the Bush policy a centerpiece of his domestic campaign,
mentioning it explicitly in his acceptance speech at the Democratic
National Convention) 2 The biotechnology industry has taken a keen
*

General Counsel, The President's Council on Bioethics. The author would like to

thank the Yale Journalof Health Policy, Law, & Ethicsfor soliciting this contribution. Special
thanks also to Michelle Powers, Yuval Levin, Eric Cohen,John A. Ritsick, and Leigh
Fitzpatrick Snead for their comments and support. All views expressed in this Essay are the
author's own and are not meant to reflect the official position of the Council or the United
States government.
1. See Amy Goldstein & Mike Allen, Bush Backs PartialStem Cell Funding, WASH. POST,
Aug. 10, 2001, at Al; Katharine Q. Seelye, Bush Gives His Backing for Limited Research on
Existing Stem Cells, N. Y. TIMES, Aug. 10, 2001, at Al.
2. There have been a number of Congressional hearings illustrating the prominence
of the issue. See Embryonic Stem Cell Research: Exploring the Controversy: HearingBefore the Senate
Commerce Subcomm. on Science, Technology & Space, 108th Cong. (2004); Adult Stem Cell
Research: Hearing Before the Senate Commerce Subcomm. on Science, Technology & Space, 108th
Cong. (2004); Hearing on Advances in Adult and Non-Embryonic Stem Cell Research: Hearing
Before the Senate Commerce Subcomm. on Science, Technology & Space, 108th Cong. (2004);
Opportunities and Advancements in Stem Cell Research: Hearing Before the Subcomm. on Criminal
Justice, DrugPolicy & Human Research of the Comm. on Government Reform, 107th Cong. (2002);
see also Laurie McGinley, Stem-Cell Research Stirs PassionateDebate and ChangingPolitics, WALL
ST. J., July 9, 2001, at A30 (describing efforts of various advocacy organizations and
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interest in stem cell research as a possible avenue for medical therapies;
one study suggests that as of 2002 private sector companies had spent an
aggregate of $208 million on research and development of stem cell
technologies.3 In response to the policy, there has been a flurry of state
legislation proposed and enacted, with some states affirming and others
Finally, the great
condemning the Administration's approach.
prominence of the national and international debate on human cloning
has drawn further attention to the issue of embryonic stem cell research
(and by extension, the Bush policy), given that one application of somatic
cell nuclear transfer is the production of cloned human embryos from
which stem cells may be derived (so-called "Therapeutic Cloning") .
To date, the significance of the Bush stem cell policy has been framed
and publicly debated in terms of its practical import: Does it impede the
scientific and medical progress that the research seems to promise? Is it
adequately protective and respectful of embryonic human life? Aside from
its great practical significance, however, the Bush policy is arguably one of
the most important recent legal developments for the field of bioethics for
an additional reason: its deep pedagogical significance. The Bush policy
provides an unparalleled window into the nature and substance of
"bioethical regulation" within the unique framework of the American
system of government. And it does so in dramatic fashion, against the
backdrop of some of the most enduring and vexing questions in all of
bioethics: What is owed to developing human life, and how does this

scientists); Alexa H. Bluth & Laura Mecoy, Boxer, Jones Split on Stem-Cell Issue, SACRAMENTO
BEE, Aug. 11, 2004, at A3; Judith Graham, Quest for Cures Spurs Fierce Debate, CHI. TRIB., July
27, 2004, at C16; Senator John Kerry, Speech at the 2004 Democratic National Convention
(July 29, 2004), at http://www.johnkerry.com/pressroom/speeches/spc_2004_0729.html.
3. Michael J. Lysaght & Anne L. Hazlehurst, Private Sector Development of Stem Cell
Technology and Therapeutic Cloning,9 TISSUE ENGINEERING 555, 557 (2003).

4. SeeJudith Graham, States Are Wrestling with Stem-Cell Issues, CHI. TRIB., Apr. 6, 2004, at
Cl (noting state efforts in California, New Jersey, Illinois, Connecticut, Maryland,
Massachusetts, Minnesota, Pennsylvania, New York, Rhode Island, Tennessee, and
Washington); Carl Ingram, Stem Cell Initiative Certifiedfor Balloting, L.A. TIMES, June 4, 2004,
at Al; Jeffrey Krasner, Massachusetts Legislature Debates Stem Cell Research Bill, BOSTON GLOBE,
May 2, 2003, at Al. For a list of pending and recently enacted state laws relating to
embryonic stem cell research, see Lori Andrews, Legislators as Lobbyists: Proposed State
Regulation of Embryonic Stem Cell Research, Therapeutic Cloning and Reproductive Cloning, in
PRESIDENT'S COUNCIL ON BIOETHICS, MONITORING STEM CELL RESEARCH (2004) [hereinafter
PRESIDENT'S COUNCIL].

5. See, e.g., Woo Suk Hwang et al., Evidence of PluripotentHuman Embryonic Stem Cell Line
Derivedfrom a Cloned Human Blastocyst, 303 Sci. ExPREss 1669 (2004).

THE PEDAGOGICAL SIGNIFICANCE OF THE BUSH STEM CELL POLICY

obligation stand in relation to the aim of science to advance knowledge
with the ultimate aspiration of alleviating human suffering? Reflecting on
the nature and scope of the policy yields insights into a number of crucial
matters that are central to the problem of whether and how to govern
science and medicine according to bioethical principles. This Essay will
briefly explore five areas in which the Bush policy is thus instructive: (1)
the conceptual understanding of "regulation" as a legal category; (2) the
principles of federalism; (3) the significance of federal funding; (4) the
nature of governance according to a particular type of moral principle
(e.g. "bright line"); and (5) the influence of political prudence and respect
for pluralism.
I. THE BUSH POLICY

Before proceeding to a discussion of the lessons of the Bush policy, it
is useful to articulate briefly the contours of the policy itself. To
understand the current policy in its full context, one needs a brief account
of the federal government's historical role in the regulation of human
embryo research. In 1975, a federal rule was enacted providing that "[n]o
application or proposal involving human in vitro fertilization may be
funded by the Department [of Health and Human Services] [until it] has
been reviewed by the Ethical [later "Ethics"] Advisory Board and the Board
has rendered advice as to its acceptability from an ethical standpoint." In
1979, the Ethics Advisory Board (EAB) issued a report concluding that it is
ethically acceptable to provide federal funding for embryo research under
certain circumstances.
The Department did not act on this
recommendation, however, and the charter of the EAB expired in 1980.
Thereafter, the EAB was not reconstituted, though the federal rule
requiring EAB approval for federal funding for any research involving in
vitro embryos remained in effect. The result was a de facto moratorium on
federal funding for research involving human embryos until 1993, when
Congress (acting at the insistence of the newly elected Clinton
Administration) rescinded the EAB approval requirement, 8 effectively
clearing the way for the federal funding of embryo research. Before any
proposals were funded, however, the newly elected Congress intervened,
6. Ethical Advisory Boards, 45 C.F.R. § 46.204(d) (1982) (later repealed).
7. HEW Support of Research Involving Human In Vitro Fertilization and Embryo
Transfer: Report of the Ethics Advisory Board, 44 Fed. Reg. 35,033, 35,055-58 (June 18,
1979).
8. See National Institutes of Health Revitalization Act of 1993, Pub. L. No. 103-43, §

121 (c), 107 Stat. 122 (1993) (repealing 45 C.F.R. § 46.204(d)).
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attaching language to the 1996 Departments of Labor, Health and Human
Services, and Education, and Related Agencies Appropriations Act that
formally precluded the use of federal funds for "the creation of a human
embryo or embryos for research purposes; or [for] research in which a
human embryo or embryos are destroyed, discarded, or knowingly
subjected to risk of injury or death greater than that allowed for research
on fetuses in utero" under the controlling human subjects protection
regulations.9 This language (known as the "Dickey Amendment," after its
original sponsor) has been re-enacted in every HHS appropriations bill
since 1996.
Three years later, in the wake of widespread enthusiasm and
excitement in the scientific community over the first reported isolation of
human embryonic stem cells, the General Counsel of the Department of
Health and Human Services urged an interpretation of the Dickey
Amendment that would allow for federal funding of research involving
embryonic stem cells.' ° The General Counsel argued that because the
Dickey Amendment only precluded the provision of federal funding to
research in which embryos were destroyed, it would be legally permissible
to authorize federal funding for researchers who worked with stem cells
acquired from embryos that had been destroyed with only private
funding." Supporters of the Dickey Amendment, including Representative
Dickey himself, strenuously objected to this interpretation, arguing that it
contradicted the spirit of the federal law by allowing the use of public
funds in a way that would create incentives for the destruction of
embryonic human life.' 2 Secretary Shalala and President Clinton rejected
this critique, and made preparations for the federal funding of embryonic
stem cell research. 13 Before the Clinton funding policy was implemented,
however, President Bush was elected.

9. Pub. L. No. 104-99, § 128, 110 Stat. 26 (1996).
10. Memorandum from Harriet S. Raab, General Counsel of the Department of Health
and Human Services, to Harold Varmus, Director of the National Institutes of Health,
Federal Funding for Research Involving Human Pluripotent Stem Cells (Jan. 15, 1999) (on
file with the National Archives).
11. See id.
12. See Letter from Representative Jay Dickey, to Secretary of Health and Human
Services Donna E. Shalala (Feb. 11, 1999) (on file with author) (signed by seventy members
of Congress).
13. See Letter from Secretary of Health and Human Services Donna E. Shalala, to
Representative Christopher H. Smith (Feb. 23, 1999) (on file with author); see also National
Institutes of Health Guidelines for Research Using Human Pluripotent Stem Cells, 65 Fed.
Reg. 51,976 (Aug. 25, 2000).
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Against the backdrop of this twenty-five year history, President Bush
was confronted with the question of whether and how to fund stem cell
research. President Bush accepted the legal analysis of the former HHS
General Counsel, but pursued a policy that sought to combine that analysis
with the principle animating the Dickey Amendment, namely, that human
life is worthy of profound respect at all of its developmental stages (from
zygote to adult), and therefore, at the very least, the federal government
should not provide financial incentives for its destruction, even for the
4
sake of beneficial scientific research.1 President Bush thus formulated a
stem cell funding policy that would, in his words, "aggressively promote
stem cell research" without violating his aforementioned principle of
respect for human embryonic life.' 5 In practice, the Bush policy authorizes
federal funding for all forms of stem cell research that do not create
6
incentives for the destruction of human embryos.' Accordingly, research
using stem cells derived from non-embryonic (commonly referred to as
"adult") sources (e.g., from bone marrow, umbilical cord blood, etc.) are
subject to unlimited funding, as the derivation of these cells does not cause
significant or lasting harm to the donor. Similarly, federal funding is
authorized for research on those human embryonic stem cell lines derived
prior to the date of the announcement of the policy (provided that they
were obtained in a manner that observed the traditional standards of
research ethics-informed consent of the donor, etc.) . So as not to
encourage future destruction of human embryos, no federal funding is
permitted for research on embryonic stem cell lines derived after August 9,
2001. For fiscal year 2003, the Bush Administration, through NIH,
allocated $190.7 million for adult stem cell research, and $24.8 million for

14. See George W. Bush, Stem Cell Science and the Preservationof Life, N.Y. TIMEs, Aug. 12,
2001, at D13.
15. Id.
16. See id. ("Federal funding for research on existing stem cell lines will move forward;
federal funding that sanctions or encourages the destruction of additional embryos will
not.").

17. There are seventy-eight such lines that are "eligible" for federal funding. However,
before a stem cell line becomes "available" for use and distribution, it must be grown into a
stable cultured population (a scientific process) and the relevant "Material Transfer
Agreements" must be negotiated and executed (a legal process). In the summer of 2002,
only one of the eligible lines was available. In the fall 2003, that number rose to twelve. As
of August 2004, there are twenty-two lines available for use and distribution. See Nat'l Insts.
of Health, Information on Eligibility Criteria for Federal Funding of Research on Human
Embryonic Stem Cells, at http://stemcells.nih.gov/research/registry/eligibilitycriteria.asp
(last modified Aug. 11, 2004).
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embryonic stem cell research.' Additionally, the NIH, acting at the behest
of the Bush Administration, has created a "Stem Cell Task Force" which
seeks to "accelerate the pace of stem cell research by identifying the rate
limiting resources (both material and human) and [to] develop initiatives
to enhance these resources."' 9 The Bush policy imposes no restrictions on
privately funded embryonic stem cell research; indeed the Administration
clarified a previously enacted administrative rule so as to make it simpler
for otherwise federally-funded scientists and institutions to pursue
embryonic stem cell research using private funds. °
II. THE PEDAGOGICAL SIGNIFICANCE OF THE BUSH POLICY
What, then, is the pedagogical significance of the Bush policy? As
noted above, a careful consideration of the policy's scope and substance
yields at least five different (yet related) insights into the nature of
bioethical regulation in the United States. Each will be discussed
separately.
A. "Regulation"as a Legal Concept
The first lesson is that "regulation" is a complex and multifaceted
concept in American law. Regulation is not simply a matter of proscription
and permission. Rather, it is a spectrum of legal activity by which the
government can voice (or not voice, as the case may be) the values and
priorities of the polity. At one end of the spectrum lies prohibition, in
which the government forbids a given activity. The most obvious and
dramatic example of this form of regulation is criminal proscription. At
the other end lies affirmative encouragement, whereby the government
18. See U.S. Dep't of Health & Human Servs., HHS Fact Sheet: Embryonic Stem Cell
Research (July 14, 2004), at http://www.hhs.gov/news/press/2004pres/20040714b.html
[hereinafter HHS Fact Sheet]. This marks the first time in history that federal funds have
been allowed for research that requires the destruction of human embryos.
19. Nat'l Insts. of Health, NIH Stem Cell Task Force, at http://stemcells.nih.gov/
policy/taskForce/ (last modified Oct. 28, 2004). Such initiatives have included grants and
awards for infrastructure and training to improve distribution and development of
approved cell lines and programs to train researchers in areas such as culture techniques.
More recently, the NIH announced plans to open a "National Embryo Stem Cell Bank" for
approved lines, in an effort to increase their availability to researchers. See Letter from
Secretary of Health and Humans Services Tommy G. Thompson, to Representative J.
Dennis Hastert, Speaker, U.S. House of Representatives (July 14, 2004) (on file with
author); see also HHS Fact Sheet, supra note 18.
20. See HHS Fact Sheet, supra note 18.
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rewards behavior that the polity deems worthwhile and useful. The most
obvious example of this form of regulation is the provision of government
funding. In between these poles of prohibition and encouragement lie
myriad mechanisms by which the government speaks, including, among
other things, recordkeeping (showing the government's view that
"attention must be paid"), silence (signifying governmental permission
without explicit endorsement), and permission with conditions (signaling
a qualified endorsement of the underlying activity, with acknowledgement
that some measure of oversight is required).
The Bush policy vividly illustrates the complexity of "regulation" as a
legal concept by incorporating elements from across this spectrum. The
policy adopts a posture of silence toward privately sponsored stem cell
research that involves the destruction of human embryos, signaling the
federal government's permission without explicit endorsement of this
practice. At the same time, it provides significant financial incentives for
stem cell research that does not involve the present and future destruction
of human embryos, showing the federal government's endorsement and
approval of this species of research. The significance of federal funding is
further expanded and amplified in Section II.C.
B. Principles ofFederalism
The Bush policy further illustrates how matters of federalism-both
implicated in the context of bioethical
horizontal 21' and vertical 2 -are
governance. Principles of horizontal federalism play an important role in
the formulation and implementation of public policy that touches and
concerns bioethics. In making such policy, each co-equal branch must act
within the boundaries of its own enumerated powers, while respecting the
prerogatives and domains of the others. This process is brought into sharp
relief by a reflection on the Bush policy's origins and operation, described
above. The Bush policy was written against the backdrop of the nearly
thirty-year history of give and take between the executive and legislative
branches over the question of federal funding for embryo research. As
discussed previously, this inter-branch dialogue culminated in the
enactment of the Dickey Amendment, whereby the legislative branch,
21. "Horizontal federalism" refers to the relationship between and among the
legislative, executive, and judicial branches of the federal government. See, e.g., L. Harold
Levinson, The Legitimate Expectation That Public Officials Will Act Consistently, 46 AM. J. COMP.
L. 549, 551-52 (1998).
22. "Vertical federalism" denotes the relationship between the federal government and
state governments. See id. at 552.

YALE JOURNAL OF HEALTH POLICY, LAW, AND ETHICS

V: 1 (2005)

acting pursuant to its constitutionally enumerated spending power,
formally proscribed the use of federal funds for research in which human
embryos are destroyed or discarded. In formulating a policy governing
stem cell research and its funding, the Bush Administration (like the
Clinton Administration before it) was required to work within the
framework provided by Dickey out of respect for the federalist principle of
separation of powers. The Bush policy accepted the Clinton
Administration's refined interpretation of Dickey, but chose a policy that
upheld a broad conception of the principle of respect for embryonic
human life that provided the foundation for the original amendment.
Thus, the Bush policy demonstrates both an acknowledgement of
Congress's sole authority to appropriate federal funds and a robust
exercise of the President's authority as head of the executive branch to
allocate the appropriated funding according to the Administration's
priorities.
In similar fashion, reflection on the Bush policy lends key insights into
principles of vertical federalism in the context of bioethical governance. In
enacting public policy, both state and federal governments are limited by
their respective jurisdictional mechanisms. By virtue of the general police
power to safeguard the health, welfare, and morals of citizens, states enjoy
wide latitude to legislate according to bioethical principles. 3 By contrast,
the federal government is somewhat more limited in its options, consigned
to act only pursuant to powers enumerated by the Constitution. 4 This
division of responsibility allows in some cases for action and reaction
between and among the federal and state governments.
Such is the case with the Bush policy. The Bush policy illustrates the
use of the jurisdictional nexus of federal spending: The Administration is
able to set ethical conditions on those practices to which it provides
financial assistance, while remaining silent (and thus uninvolved) with
respect to privately funded stem cell research. This leaves the state
governments free to affirm or reject the policy within their own borders.
23. See, e.g., Gibbons v. Ogden, 22 U.S. (9 Wheat.) 1, 203 (1824) ("Inspection laws,
quarantine laws, health laws of every description, as well as laws for regulating the internal
commerce of a State .... No direct general power over these objects is granted to Congress;
and, consequently, they remain subject to State legislation."); see also Washington v.
Glucksberg, 521 U.S. 702 (1997) (upholding assisted-suicide ban as rationally related to
legitimate state interest).
24. See United States v. Morrison, 529 U.S. 598, 607 (2000) ("Every law enacted by
Congress must be based on one or more of its powers enumerated in the Constitution.");
United States v. Lopez, 514 U.S. 549, 552 (1995) (same); McCulloch v. Maryland, 17 U.S. (4
Wheat.) 316, 405 (1819); Marbury v. Madison, 5 U.S. (1 Cranch) 137, 176 (1803).
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Many states have taken this opportunity. On one end of the spectrum,
there are states such as Louisiana, which bans destructive embryo research
altogether." On the other end of the spectrum, there are states such as
New Jersey and California,27 which have explicitly endorsed embryonic
28
stem cell research and cloning for biomedical research.
C. The Significance of FederalFunding
The Bush policy also offers noteworthy lessons regarding the nature
and significance of federal funding. The U.S. government is a major
29
provider of funds and resources for scientific and medical research. This
is reflective of the esteem in which the American polity holds the scientific
enterprise, as well as its great concern for the alleviation of human
suffering. Federal funding has long played a significant role in the
regulation of medicine and science according to bioethical principles. In
the first instance, it is a jurisdictional nexus, allowing for the regulation of
activities that might otherwise lie beyond the enumerated powers of the
federal government by attaching certain conditions to the provision of
funds.30 But perhaps more importantly for the present discussion, federal
funding is a powerful device whereby the government expresses the polity's
approval, disdain, or studied neutrality toward specified conduct. The
government is under no obligation to provide federal funding for most
activities-including those activities in which individuals may engage as a
matter of constitutional right.3' Thus, the provision of federal funding can
25. See LA. REV. STAT. ANN. § 9:129 (West 1986). It is important to note, however, that

Louisiana defines "embryo" as the product of the union of egg and sperm, thus excluding
cloned embryos from legal protection. See LA. REv. STAT. ANN. § 9:121 (West 1986).
26. See N.J. STAT. ANN. 26:2Z-2 (West 2004).
27. See S.B. 322, 2003-04 Sess. (Cal. 2004) (signed by Governor Davis on Sept. 24, 2003).
28. In November 2004, California voted in a statewide referendum on a measure that
both amends the state constitution to establish a "Right to Conduct Stem Cell Research,"
and calls for the issuance of three billion dollars of general obligation bonds to provide
funding for stem cell research. See California Stem Cell Research and Cures Initiative,
7
Proposition 71 (Cal. 2004), www.voterguide.ss.ca.gov/propositions/prop ltext.pdf.
29. For a detailed breakdown of the funding from the National Institutes of Health for
various research projects, see Nat'l Insts. of Health, Estimates of Funding for Various
Diseases, Conditions, Research Areas, at http://www.nih.gov/news/fundingresearch
areas.htm (last visited Oct. 15, 2004).

30. See, e.g., United States v. Butler, 297 U.S. 1, 66 (1936) ("[T]he power of Congress to
authorize expenditure of public moneys for public purposes is not limited by the direct
grants of legislative power found in the Constitution.").
31. See Rust v. Sullivan, 500 U.S. 173 (1991); Harris v. McRae, 448 U.S. 297 (1980);
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confer legitimacy on a given enterprise, signaling its worthiness for the
allocation of otherwise scarce funds. The withholding of federal funds can
signify a variety of sentiments: a lack of faith in the worthiness (moral or
otherwise) of the enterprise, moral caution or affirmative disdain for the
activity in question, or simply the judgment that there are more important
priorities worthy of the expenditure of limited resources.
The Bush policy is instructive in this regard. It does, as mentioned
above, utilize funding as a jurisdictional nexus. But it also conveys a
message regarding the priorities of the Administration. First, it requires
the federal government to adopt a posture of neutrality in the debate over
the moral propriety of destructive embryo research. The Bush policy
affirmatively and deliberately withholds the federal government's official
approval for such practices, though it does allow these practices to proceed
in the private sector. As such, no taxpayer is compelled to pay for and
encourage an activity (i.e., embryo destruction) that a significant portion
of the American public finds morally troublesome. 2 At the same time, the
Bush policy was designed in an effort to reflect the government's
commitment "to fully exploring the promise and potential of stem cell
research 3 3 without running afoul of the particular moral and ethical
principles set forth and embraced by President Bush in announcing the
policy.
D. Governance According to a "BrightLine" Moral Principle
The Bush policy provides a rich and complex example of one
particular approach to "bioethical governance." It is not driven by a
utilitarian weighing of commensurate values, but rather begins with a clear
moral standard that may not be transgressed. In his August 9, 2001 speech,
and in an editorial printed in the New York Times three days later, President
Bush said: "There is at least one bright line: We do not end some lives for
the medical benefit of others. For me, this is a matter of conviction: a

Maher v. Roe, 432 U.S. 464 (1977).
32. See Matthew Nisbit, Public Opinion About Stem Cell Research and Human Cloning, 68
PUB. OPINION Q. 131, 135 (2004) (noting that in two separate Gallup Polls asking
respondents whether they found medical research using cells obtained from human
embryos to be morally acceptable or morally wrong, more than half in both polls said it is
.morally wrong"). It is important to note, however, that polls regarding public support for
embryonic stem cell research have varied widely: Many show widespread support for the
practice, while others show widespread opposition. See generally NAT'L INSTS. OF HEALTH,
REPORT OF THE HuMAN EMBRYO RESEARCH PANEL 44-45 (Sept. 1994).

33. See HHS Fact Sheet, supranote 18.
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belief that life, including early life, is biologically human, genetically
distinct, and valuable. ' 4 This is the moral and ethical foundation upon
which the Bush policy is erected. The Administration's stated desire to
better the human condition by eradicating dreaded diseases and
debilitating injuries, and its attendant enthusiasm and support for
scientific research aimed at these goals, are thus expressed and acted upon
within the boundaries of this moral framework. Accordingly, the Bush
policy is designed to endorse and actively promote all stem cell research
the future
that does not encourage
(including embryonic)
instumentalization and destruction of human embryos.
This bright line policy stands in contrast to the balancing approaches
espoused by other commentators and governmental advisory bodies. Both
the NIH Human Embryo Panel and President Clinton's National Bioethics
Advisory Commission (NBAC) promoted the view that while human
embryos deserve special respect as a form of developing human life, it is
possible to balance this respect against the benefits of scientific research
that might be achieved through research that necessarily requires the
destruction of such embryos. 5 This approach led both bodies to
recommend that such research was ethically acceptable, and that the
federal government should fund such research, subject to various
conditions. The NIH Human Embryo Panel went somewhat further,
issuing a qualified endorsement of the creation of embryos solely for the
sake of research. 6
The policy also teaches that policies originating from this species of
bioethical governance-based on a bright line moral principle rather than
a balancing of values or "compromise" (in the conventional sense)-are
not alterable on the basis of a showing that the benefits of transgressing
the established boundary would be higher than originally thought-even
by orders of magnitude. Put concretely, the Bush policy (given the species
of bioethical regulation that it represents) would almost certainly not be
revised or reversed, even if tomorrow there were incontrovertible evidence
that greater benefits could be realized by federally funding future
derivations of embryonic stem cell lines. To do so would undermine the
very "bright line" that animates the entire policy, namely, that destruction
of human embryos should not be encouraged or incentivized by the
promise of future federal funding.

34. George W. Bush, Stem Cell Science and the Preservation of Life, N.Y. TIMES, Aug. 12,
2001, at D13.
35. See PRESIDENT'S COUNCIL, supranote 4, at 82-84.
36. See NAT'L INSTS. OF HEALTH, supranote 32, at 44-45.
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E. PoliticalPrudence and Respect for Pluralism
While the Bush policy provides insight into a particular species of
moral governance, it also teaches one way in which the formulation of
bioethical policies is influenced by considerations of political prudence
and respect for pluralism. Although the moral foundation of the Bush
policy is a view that human beings are worthy of maximal respect
regardless of their developmental stage and that ending some human lives
for the medical benefit of others is unethical, the Bush policy does not
seek to ban destructive embryo research altogether. To the contrary, it
steers a more moderate course, merely withholding the government's
affirmative endorsement of the practice by way of federal funding. What is
the significance of this tension between the Bush policy's moral principle
and its practical effect? One can only speculate, but there are several
possibilities (or combinations of possibilities).
First, this apparent disconnect might reflect the Administration's
acknowledgement of the moral, ethical, and legal discourse as it has
evolved over the past thirty years. As a matter of historical context, the
debate over the federal government's role vis-a-vis embryo research has
been consistently framed in terms of funding rather than permission and
proscription more broadly. The battle lines, so to speak, were drawn before
the Bush Administration came on the scene. Indeed, the issue of stem cell
research was presented to the Administration in the form of a question
about funding and in the legal context of interpreting and implementing
the Dickey Amendment.
Second, the modest nature of the Bush policy might be interpreted as
a certain type of incrementalism. That is, it might bespeak the
Administration's desire to avoid overreaching in such a controversial
bioethical context. There is a deep divide within the American polity on
the question of what is owed to human embryos, and an Administration
that sought to impose a novel and restrictive policy in an area where there
has historically been little government involvement risks polarization and
backlash. Thus, it is possible to construe the Bush policy as reflecting the
view that a judicious incrementalism is the most appropriate course for
winning public support over the long term for policies that originate from
the bright line principle that embryonic human life is inviolable. The limit
on federal funding might thus be interpreted as laying the groundwork for
a larger effort to convince the American public of the Administration's
views regarding the respect owed to human embryos more generally.
Finally, the restrained nature of the Bush policy might also (or
alternatively) serve to demonstrate how considerations of pluralism can
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affect the formulation of bioethical public policy. While the Bush
approach begins with the moral judgment that human embryos should not
be instrumentalized or destroyed for the sake of another's medical benefit,
the ultimate legal expression of this policy implicitly acknowledges that
there is great division among the American citizenry on this point by
remaining neutral on the ultimate question of the legal permissibility of
embryo research. The policy does not ban the destruction of human
embryos to derive embryonic stem cells, but it does withhold the
government's official approval and refuses to compel American taxpayers
to subsidize an activity that is a source of great moral and ethical disquiet
for a significant portion of the population.3 7 The Bush policy could thus be
seen as an example of how the government can express its ethical approval
(or disapproval) of a particular type of scientific activity while respecting
the deep disagreements that persist in society.

37. Polling in this area has reached varied results, not surprisingly turning largely on

how the question is framed and what information is provided to respondents. In polls in
which respondents are asked if they support "stem cell research" but are not explicitly told
that the derivation of embryonic stem cells requires the destruction of human embryos,
opposition ranges from twenty-eight percent to thirty-five percent. See Press Release, Nat'l
Annenberg Election Survey, Public Favors Stem Cell Research, Annenberg Polling Data
Show (Aug. 9, 2004), http://www.annenbergpublicpolicycenter.org/naes/2004 03_stemcell_08-09_pr.pdf (finding that twenty-eight percent of respondents opposed "federal
funding of research on diseases like Alzheimer's using stem cells taken from human embryos");
Press Release, Pew Forum on Religion & Public Life, Cloning Opposed, Stem Cell Research
Narrowly Supported (Apr. 9, 2002), http://pewforum.org/publications/surveys/
bioethics.pdf (finding that thirty-five percent of respondents oppose federal funding for
"stem cell research"). By contrast, in polls where respondents are explicitly told that the
research requires the destruction of human embryos (but without explicit reference to the
possible therapeutic benefits of the research), opposition increases to between fifty-three
percent and sixty-one percent. See Poll: Americans Oppose Destroying Human Embryos, Cloning,
TIDINGS, Aug. 27, 2004, http://www.the-tidings.com/2004/0827/stemcell.htm (showing
that 61.4% of respondents oppose federal funding of stem cell research in which "embryos
are destroyed in their first week of development"); Press Release, Nat'l Right to Life
Comm., Majority Opposes Tax Funding of Stem Cell Research That Kilts Human Embryos
(Aug. 23, 2004) (showing that fifty-three percent of respondents opposed "using tax dollars
to pay for the kind of research that requires the killing of human embryos."),
http://www.nrlc.org/Killing-Embryos/Release082304.html. It does not appear that any
public survey has yet been conducted in which respondents are advised explicitly of both the
possible therapeutic benefits and the fact that embryos are destroyed in the derivation
process.
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CONCLUSION

In sum, the Bush stem cell policy is one of the most significant recent
legal developments with bioethical implications-not merely for its
practical impact on scientific research or the use and disposition of human
embryos, but also for what it teaches about the nature of bioethical
regulation in the United States. As this Essay has attempted to show, a
careful consideration of the Bush policy leads one to key insights relating
to the manifold character of regulation, principles of federalism, the
significance of federal funding, the nature of governance according to a
"bright line" moral principle, political prudential judgments, and the
impact of a respect for pluralism in the bioethical context. Such insights
are crucial to a robust understanding of the still raging debate over the
federal regulation of and support for embryonic stem cell research, as well
as to a comprehensive appreciation of "bioethical regulation" more
generally.

